Juvion Health Sciences
dedicated to delivering proactive solutions to maintain mobility throughout life
JUVION MISSION
JUVION DEVELOPS ADVANCED THERAPEUTICS AIMED TO
PRESERVE NEURON-MUSCLE CONNECTIVITY,
ADDRESS IMMOBILITY PLUS SARCOPENIA,
AND EXTEND HEALTHSPAN.
Aging and conditions such as Sarcopenia result in decreased mobility due to weakening of neuron-muscle connections. Juvion Health Sciences leverages pioneering neuromuscular aging research with an exclusive in vivo platform, amalgamating AI and machine vision together robotics, to discover next-generation therapeutics based on natural products. These therapeutics are designed to fortify the motor system and preserve motor ability throughout adult life.
JUVION TEAM
Dr. Soumya Banerjee Ph.D., cofounder & CEO [center left] in
Dr. Jamshid Asadzadeh Ph.D., cofounder & CSO [center right] in
François Randin MBA, COO [right] in
Prof. Brian D. McCabe Ph.D., cofounder & chairperson of the scientific advisory board [left] in
Dr. Victor Lobato Rios Ph.D., engineering [not pictured] in
